/

PTN

Palatin Technologies, Inc.Closed

8.19−0.36 −4.21%USD

NasdaqCM · as of Oct 13, 16:00 ET · 15m delay

Open

8.93

Prev close

8.55

Day range

8.169.07

52-week range

5.6131.00

Volume

14.21K0.23×

Mkt cap

14.59M

P/E ttm

—

Fwd P/E

-4.42

EPS ttm

-2.96

Div yield

0.00%

Earnings

—

From 52w high

−73.58%

Price Chart

Yahoo Finance · delayed

PTNOct 13, 2026O 8.93H 9.07L 8.14C 8.19−0.36 (−4.21%)Vol 14.20K

SMA 5010.02
SMA 20014.74

1Y change +12.97% since Oct 13, 2025 close539 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

PTN Palatin Technologies, Inc. · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: −12.96%
1 month: −30.59%
3 months: −7.46%
6 months: −60.03%
Year to date: −46.75%
1 year: +12.97%

Valuation & ownership

Market cap: 14.59M
Enterprise value: 7.32M
P/E (ttm): —
Forward P/E: -4.42
PEG ratio: 1.62
Price / book: 2.18
Price / sales (ttm): 1.11
EV / EBITDA: -0.85
EPS (ttm): -2.96
EPS (forward): -1.86
Beta (5y monthly): -0.01
Dividend yield: 0.00%
Payout ratio: 0.00%
Shares outstanding: 1.78M
Float: 1.49M
Short % of float: 21.54%
Short ratio (days): 2.69
Held by insiders: 8.11%
Held by institutions: 50.11%
Avg volume (3m): 62.88K
50-day average: 10.02
200-day average: 14.78
52-week change: +12.97%
S&P 500 52-week: +17.03%

Technicals (daily)

RSI (14): 35.4
vs 50-day SMA: −18.28%
vs 200-day SMA: −44.45%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▼ below
ATR (14) % of price: 12.04%
Realised vol (20d, ann.): 80.9%
From 52-week high: −73.58%
From 52-week low: +45.99%

ANR

Analyst Consensus

3 analysts

Consensus

Strong buy

1.33 on a 1 (strong buy) – 5 (sell) scale

Mean target

53.50

+553.24% implied

Low 47.50Median 53.00High 60.00

Recommendation trend

Now3 / 0 / 0

Buy / hold / sell counts

Financial Snapshot

DES

About Palatin Technologies, Inc.

Yahoo Finance profile

Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity completed Phase 2 clinical trial; completed a phase 2 of diabetic nephropathy It also provides pl9643 for dry eye disease; and oral PL8177 for inflammatory bowel diseases. licensing arrangements and other strategic transactions to advance and maximize the value of certain product candidates and program for the treatment of retinal diseases and with Altanispac Labs for PL9643 for the treatment of dry eye disease; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Princeton, New Jersey.

Sector: Healthcare
Industry: Biotechnology
Employees: 25
Headquarters: Princeton, NJ, United States
Website: palatin.com
Officers: Dr. Carl Spana Ph.D. Co-Founder, President, CEO & Director
Mr. Stephen T. Wills C.P.A., MST CFO, COO, Executive VP, Treasurer & Secretary
Burns McClellan Vice President of Investor Relations

SEAS

Seasonality · PTN

2007–2026 · monthly returns

Strongest month Nov +12.59%Weakest month Aug −10.35%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	-4.4	42.1	-16.7	16.0	-30.6	-23.0	-28.6	29.7	-11.2	-7.7			−46.7%
2025	-18.0	0.0	-36.3	-65.5	-50.0	40.0	50.0	-2.8	-22.4	-16.0	193.8	-21.3	−72.3%
2024	5.8	-52.3	-7.0	-0.5	-3.2	8.3	-12.3	-4.7	-45.4	39.3	-8.1	-2.6	−72.1%
2023	55.5	-20.4	-13.2	-17.1	7.5	-14.3	1.9	-3.7	-26.7	36.4	-2.9	99.0	+55.5%
2022	-11.8	-11.1	15.0	-17.4	-5.3	-22.2	0.0	-28.3	17.9	-6.3	-28.8	-35.2	−79.9%
2021	29.4	-11.4	-11.5	-10.1	-11.3	10.9	-16.4	-5.9	-8.3	-6.8	73.2	-28.2	−25.0%
2020	-16.7	-21.5	-17.6	14.3	6.3	0.0	13.7	-5.2	-14.5	-17.0	12.8	54.5	−12.8%
2019	-2.8	43.5	-1.0	26.5	8.1	-13.4	-21.6	-1.1	1.1	-11.0	2.5	-6.0	+9.9%
2018	16.3	-7.0	17.2	10.1	-7.5	-12.6	-1.0	5.2	-1.0	-10.0	-10.0	-12.3	−17.4%
2017	-19.6	-9.8	-10.8	33.3	-20.5	22.9	-2.3	2.4	53.5	13.6	21.3	-5.5	+68.6%
2016	-27.3	2.1	10.2	9.3	-10.2	-17.0	84.1	-37.0	23.5	-17.5	57.7	-37.8	−22.7%
2015	-2.7	32.4	8.5	-10.8	-3.3	1.1	7.9	-11.5	-4.7	-3.7	-10.3	-5.7	−9.6%
2014	37.0	6.0	16.0	1.6	-13.6	-8.3	1.0	-15.0	9.4	-32.3	33.3	-13.1	+0.0%
2013	-1.7	3.4	-1.6	0.0	3.3	0.0	12.9	-5.7	4.5	-15.9	19.0	5.8	+21.7%
2012	25.0	14.0	28.1	-11.0	-6.2	-18.0	30.0	-6.2	13.1	2.9	-11.3	-4.8	+50.0%
2011	-17.8	-22.5	19.8	-12.6	1.1	40.7	-18.0	-32.4	-28.2	25.5	-17.2	-24.5	−70.4%
2010	-21.6	-13.8	4.0	23.1	-18.8	-30.8	0.0	0.0	-10.0	-15.4	-6.6	5.5	−63.5%
2009	0.0	-11.1	37.5	27.3	64.3	8.7	8.0	18.5	6.3	-8.8	-19.4	48.0	+311.1%
2008	50.0	26.7	-26.3	-7.1	-19.2	-9.5	-26.3	0.0	0.0	-14.3	-25.0	0.0	−55.0%
2007	14.2	-10.7	-11.1	9.2	-4.0	2.1	-7.6	-63.4	-40.3	0.0	-35.0	-23.1	−90.2%

INSD

Insider Activity · PTN

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

0 shares

Sells, 6 months

— shares

Net shares

Net change in insider shares

—

Date	Insider	Transaction	Shares	Value
Dec 23, 2025	Wills Stephen TChief Operating Officer	Sale at price 16.74 per share.	565	$9.46K
Dec 8, 2025	Prendergast John K. A. Ph.D.Director	Stock Award(Grant) at price 0.00 per share.	2.6K	—
Dec 8, 2025	Spana CarlChief Executive Officer	Stock Award(Grant) at price 0.00 per share.	885	—
Dec 8, 2025	Wills Stephen TChief Operating Officer	Stock Award(Grant) at price 0.00 per share.	770	—
Dec 8, 2025	Dunton Alan WilliamDirector	Stock Award(Grant) at price 0.00 per share.	2K	—
May 6, 2025	De Veer Robert K JrDirector	Purchase at price 0.10 per share.	100K	$10.18K

PTN

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

PTN

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About Palatin Technologies, Inc.

Seasonality · PTN

Insider Activity · PTN

Congress Trades · PTN

Investors Holding PTN

Investors Holding PTN

Congress Trades · PTN

Insider Activity · PTN

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About Palatin Technologies, Inc.

Earnings & Dividends

News

Seasonality · PTN